Zobrazeno 1 - 10
of 9 247
pro vyhledávání: ''
Publikováno v:
British Journal of Dermatology. 186:609-619
Epidermolysis bullosa (EB) encompasses a heterogeneous group of inherited skin fragility disorders, with mutations in genes encoding the basement membrane zone (BMZ) proteins that normally ensure dermal-epidermal integrity. Of the four main EB types,
Autor:
Emily Edson-Heredia, A Prakash, Natasha Atanaskova Mesinkovska, Russel Burge, Jake Macey, Brett A. King, Helen Kitchen, Natalie V. J. Aldhouse
Publikováno v:
British Journal of Dermatology. 186:849-860
Background The content validity (appropriateness and acceptability) of patient-reported outcome (PRO) measures for scalp hair loss, eyebrow loss, eyelash loss, nail damage and eye irritation has been demonstrated in adults with alopecia areata (AA) b
Autor:
S. Lambrechts, R.J. Vermeulen, M.G.H.C. Reinders, Klara Mosterd, J.R. van Rheenen, P.A.W.K. Kessler, Maaike Vreeburg, M. van Geel, B. Cosgun, Babette J A Verkouteren, M. Klaassens
Publikováno v:
British Journal of Dermatology, 186(2), 215-226. Wiley
Linked Comment: E. Epstein. Br J Dermatol 2022; 186:203. Plain language summary available online
Autor:
Knut Rudi, Petter Gjersvik, G. Hedlin, Håvard Ove Skjerven, Riyas Vettukattil, Marissa LeBlanc, Anne Catherine Staff, Linn Landrø, Eva Maria Rehbinder, K. C. Lødrup Carlsen, Guttorm Haugen, Kim M Advocaat Endre, Cilla Söderhäll, Christine M. Jonassen, Björn Nordlund
Publikováno v:
British Journal of Dermatology
Summary Background Diagnosing atopic dermatitis (AD) in infants is challenging. Objectives To determine the incidence and persistence of eczema and AD in infants using the UK Working Party (UKWP) and Hanifin and Rajka (H&R) criteria. Methods A cohort
Publikováno v:
British Journal of Dermatology
British Journal of Dermatology, Wiley, 2022, 186 (1), pp.59-68. ⟨10.1111/bjd.20659⟩
The British Journal of Dermatology
British Journal of Dermatology, Wiley, 2022, 186 (1), pp.59-68. ⟨10.1111/bjd.20659⟩
The British Journal of Dermatology
Summary Background Data on treatment exposures for psoriasis and poor COVID‐19 outcomes are limited. Objectives To assess the risk of hospitalization or in‐hospital mortality due to COVID‐19 by treatment exposure in patients with psoriasis. Met
Publikováno v:
British Journal of Dermatology. 186:167-173
Summary Background Skin adnexal tumours (SATs) comprise a diverse range of neoplasms, which are difficult to diagnose clinically. They present in paediatric and adult populations, and may be indicative of an underlying genetic syndrome. There is a la
Autor:
J.-S. Zeng, F.-Q. Li, Y. Zhang, J.-X. Yang, B. Yin, C.-W. Cao, G.-Z. Chen, Yuping Ran, Aibo Wang, Y.-Y. Xiao, Jiahong Yu, Xue Qi Chen, L.-Y. Xi, W.-H. Pan, M. Zhu, B.-L. Dong, N. Yu, Y.-P. Jiang, H.-Q. Huang, W.-W. Wu, P. Abliz, Y. Guo, H. Sang, R. Li, L. Ma, X.-F. Li, Y. Jin, H.-F. Liu, Z.-H. Liu, Z.-S. Tong, D.-M. Shi, D.-Y. Zheng, X.-C. Xiong, M. Fu, Zhe Wan, Y. Wang, W. Chen
Publikováno v:
British Journal of Dermatology. 186:705-712
Tinea capitis is still common in developing countries, such as China. Its pathogen spectrum varies across regions and changes over time.This study aimed to clarify the current epidemiological characteristics and pathogen spectrum of tinea capitis in
Autor:
J. Gottlieb, S. Debarbieux, Enno Schmidt, Jacques Benichou, Christophe Bedane, Vivien Hébert, O. Guérin, Pascal Joly, S. Bastos, Claudio Feliciani, C. Boulard, Saskia Ingen-Housz-Oro, Kossara Drenovska, Joost M. Meijer, V Ferranti, M.-A. Richard, Hana Jedličková, N. Schumacher, Michel d’Incan, G. Chaby, A. Roussel, L. Lunardon, Frédéric Caux
Publikováno v:
British Journal of Dermatology
British Journal of Dermatology, In press, ⟨10.1111/bjd.20593⟩
BRITISH JOURNAL OF DERMATOLOGY, 185(6), 1232-1239. Wiley
British Journal of Dermatology, Wiley, In press, ⟨10.1111/bjd.20593⟩
British Journal of Dermatology, In press, ⟨10.1111/bjd.20593⟩
BRITISH JOURNAL OF DERMATOLOGY, 185(6), 1232-1239. Wiley
British Journal of Dermatology, Wiley, In press, ⟨10.1111/bjd.20593⟩
BackgroundEuropean guidelines propose a 0 center dot 5 mg kg(-1) per day dose of oral prednisone as initial treatment for bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent and general condition of the
Autor:
M. Larue, T. Comont, Arsène Mekinian, L. Terriou, T. Cluzeau, Y. Jamilloux, M. Roux-Sauvat, Benjamin Terrier, J. Graveleau, J. Vinit, M. Gerfaud-Valentin, C. Arnaud, P. Biscay, H. Lobbes, Marie Sebert, A.F. Guedon, P. Henneton, P. Sujobert, M. Ebbo, V. Jachiet, T. Moulinet, F. Carrat, Jean-David Bouaziz, S. Ardois, A. Aouba, François Chasset, M. Heiblig, J. Rossignol, B. Faucher, Lionel Ades, E. Lazaro, E. Duroyon, N. Magy-Bertrand, A. Meyer, G. Vial, G. Boursier, B. Bienvenu, T. Hanslik, L. Sailler, Claude Bachmeyer, S. Audia, Pierre Fenaux, M. Samson, E. Flamarion, A. Audemard-Verger, B. de Sainte Marie, L.P. Zhao, E. Liozon, R. Outh, T. Weitten, R. Bourguiba, O. Kosmider, Sophie Georgin-Lavialle, J. Jeannel, G. Le Guenno, P. Hirsch, V. Lacombe, A. Mathian, S. Humbert, J. Galland, V. Guillotin, C. Deligny, Laurence Bouillet, M. Kostine, C. Dieval, P. Marianetti, A. Servettaz, B. Henriot, F. Borlot, O. Fain, A. Bigot, G. Sarrabay, S. Vinzio
Publikováno v:
British Journal of Dermatology. 186:564-574
A new autoinflammatory syndrome related to somatic mutations of UBA1 was recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic syndrome').To describe clinical characteristics, laboratory findings and
Autor:
Andrew Blauvelt, M Shah, Jashin J. Wu, Kristian Reich, Mark Lebwohl, Kenneth B. Gordon, Richard G. Langley, Hervé Bachelez, Y Zhao, B Kaplan, Kim Papp, R Sinvhal
Publikováno v:
British Journal of Dermatology. 186:466-475
BACKGROUND Risankizumab has demonstrated efficacy and safety in patients with moderate-to-severe plaque psoriasis in randomized clinical trials. OBJECTIVES To evaluate safety data from risankizumab psoriasis phase I-III clinical trials. METHODS Short